Effect of suramin on the biological activity of the two isoforms of the rat 5 alpha-reductase.
Poletti
A
A
Rabuffetti
M
M
Martini
L
L
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001665:Binding Sites; D001667:Binding, Competitive; D042944:Cholestenone 5 alpha-Reductase; D013196:Dihydrotestosterone / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007527:Isoenzymes / Q000378:metabolism; D007700:Kinetics; D009249:NADP / Q000378:metabolism; D010088:Oxidoreductases / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D051381:Rats; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000378:metabolism; D013379:Substrate Specificity; D013498:Suramin / Q000494:pharmacology*; D013739:Testosterone / Q000378:metabolism
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D011994:Recombinant Proteins; D013196:Dihydrotestosterone; D013739:Testosterone; D009249:NADP; D013498:Suramin; D010088:Oxidoreductases; D042944:Cholestenone 5 alpha-Reductase